Sigilon Therapeutics’ stock soars 550% after Eli Lilly agrees to acquire company
Eli Lilly & Co. said Thursday it has agreed to acquire Sigilon Therapeutics Inc. in a deal worth up to ...
Read moreEli Lilly & Co. said Thursday it has agreed to acquire Sigilon Therapeutics Inc. in a deal worth up to ...
Read moreA super PAC called Legalize America is launching Wednesday with backing from advocacy group the U.S. Cannabis Council and legal ...
Read moreBiotech drug developer Sagimet Biosciences is taking another shot at going public, according to a filing with the Securities and ...
Read moreEisai shares 4523, +7.37% rose sharply Thursday morning after the U.S. Food and Drug Administration’s review memo on Leqembi raised ...
Read moreHere are some of the more prominent movers on Tuesday: Stock gainers: Lowe’s Companies Inc.’s stock LOW, +1.72% jumped 1.7% ...
Read moreShares of Lifecore Biomedical LFCR, -4.96% on Monday climbed 19% to $6.40 in after-hours trading after the company said it ...
Read moreEli Lilly & Co.’s market cap neared Johnson & Johnson’s market cap on Friday, as the stock has benefited from ...
Read moreAstellas Pharma Inc. said Monday that it agreed to acquire Iveric bio Inc. for about $5.9 billion to strengthen its ...
Read moreGilead Sciences Inc. on Thursday cut one of its profit forecasts and reported first-quarter profit that missed expectations, with weaker ...
Read moreThis copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or ...
Read moreTodayheadline the independent news and topics discovery
A home-grown and independent news and topic aggregation . displays breaking news linking to news websites all around the world.
© 2024 All rights are reserved Today Headline